Open consultation

Consultation on the International Council for Harmonisation Guideline E20 for adaptive clinical trial design

Summary

The MHRA is consulting with UK stakeholders to gather feedback and comments on ICH E20, a new international guideline.

This consultation closes at

Consultation description

The MHRA is consulting with UK stakeholders to gather feedback and comments on a new international guideline on the design, conduct, analysis, and interpretation of adaptive clinical trials that provides a transparent and harmonised set of principles for the regulatory review of these studies in a global drug development program.

Documents

Ways to respond

Updates to this page

Published 24 July 2025

Sign up for emails or print this page